All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer

被引：0
|
作者：
Hesham Tawfik
Yousri Rostom
Hesham Elghazaly
机构：
[1] Tanta University,Clinical Oncology Department
[2] Alexandria University,Clinical Oncology Department
[3] Ain Shams University,Clinical Oncology Department
来源：
Cancer Chemotherapy and Pharmacology | 2013年 / 71卷
关键词：
Oral therapy; First-line chemotherapy; Metastatic breast cancer; HER2/Neu-negative;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：913 / 919
页数：6
相关论文
共 50 条
  • [1] All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer
    Tawfik, Hesham
    Rostom, Yousri
    Elghazaly, Hesham
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 913 - 919
  • [2] All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial
    Tubiana-Mathieu, N.
    Bougnoux, P.
    Becquart, D.
    Chan, A.
    Conte, P-F
    Majois, F.
    Espie, M.
    Morand, M.
    Vaissiere, N.
    Villanova, G.
    BRITISH JOURNAL OF CANCER, 2009, 101 (02) : 232 - 237
  • [3] All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial
    N Tubiana-Mathieu
    P Bougnoux
    D Becquart
    A Chan
    P-F Conte
    F Majois
    M Espie
    M Morand
    N Vaissiere
    G Villanova
    British Journal of Cancer, 2009, 101 : 232 - 237
  • [4] First-line all-oral NORCAP (vinorelbine/capecitabine) might be alternative to taxane-based chemotherapy for HER2-negative metastatic breast cancer
    Kadri Altundag
    Breast Cancer Research and Treatment, 2017, 161 : 385 - 385
  • [5] First-line all-oral NORCAP (vinorelbine/capecitabine) might be alternative to taxane-based chemotherapy for HER2-negative metastatic breast cancer
    Altundag, Kadri
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (02) : 385 - 385
  • [6] Updated analysis of an international phase II study evaluating an all-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer (MBC)
    Tubiana-Mathieu, N.
    Bougnoux, P.
    Becquart, D.
    Chan, A.
    Majois, F.
    Espie, M.
    Perrot, O.
    Villanova, G.
    Conte, P. F.
    EJC SUPPLEMENTS, 2007, 5 (04): : 223 - 223
  • [7] Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer
    Gampenrieder, Simon P.
    Bartsch, Rupert
    Matzneller, Peter
    Pluschnig, Ursula
    Dubsky, Peter
    Gnant, Michael X.
    Zielinski, Christoph C.
    Steger, Guenther G.
    BREAST CARE, 2010, 5 (03) : 158 - 162
  • [8] First-line all-oral NORCAP (vinorelbine/capecitabine) might be alternative to taxane-based chemotherapy for HER2-negative metastatic breast cancer Reply
    Cazzaniga, Marina E.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (02) : 387 - 387
  • [9] Final results of a phase II study of liposomal cisplatin - vinorelbine combination as first-line treatment in HER2/neu negative metastatic breast cancer
    Farhat, F. S.
    Temraz, S.
    Kattan, J. G.
    Ibrahim, K.
    Bitar, N.
    Haddad, N.
    Hatoum, H.
    Shamseddine, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] An all-oral combination regimen of vinorelbine and capecitabine for elderly patients with metastatic breast cancer
    Carreca, Ignazio
    Bronte, Giuseppe
    Burgio, Marco
    Carreca, Annapaola
    Piazza, Dario
    Rizzo, Sergio
    Russo, Salvatore
    ANNALS OF ONCOLOGY, 2006, 17 : 159 - 159
12345